443 related articles for article (PubMed ID: 11319922)
21. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
22. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
23. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
Stavropoulos TA; Strathdee CA
J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
[TBL] [Abstract][Full Text] [Related]
24. A modular set of helper-dependent herpes simplex virus expression vectors.
Strathdee CA; McLeod MR
Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
[TBL] [Abstract][Full Text] [Related]
25. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
26. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
Lee CY; Bu LX; Rennie PS; Jia WW
Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
[TBL] [Abstract][Full Text] [Related]
27. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
Kohno SI; Luo C; Nawa A; Fujimoto Y; Watanabe D; Goshima F; Tsurumi T; Nishiyama Y
Cancer Gene Ther; 2007 Nov; 14(11):918-26. PubMed ID: 17693992
[TBL] [Abstract][Full Text] [Related]
29. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
Bowers WJ; Howard DF; Brooks AI; Halterman MW; Federoff HJ
Gene Ther; 2001 Jan; 8(2):111-20. PubMed ID: 11313780
[TBL] [Abstract][Full Text] [Related]
30. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
Sun M; Lee J; Yu L; Geller AI
Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280
[TBL] [Abstract][Full Text] [Related]
31. An efficient selection system for packaging herpes simplex virus amplicons.
Zhang X; O'Shea H; Entwisle C; Boursnell M; Efstathiou S; Inglis S
J Gen Virol; 1998 Jan; 79 ( Pt 1)():125-31. PubMed ID: 9460933
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences.
Kwong AD; Frenkel N
J Virol; 1984 Sep; 51(3):595-603. PubMed ID: 6088785
[TBL] [Abstract][Full Text] [Related]
33. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
34. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
Logvinoff C; Epstein AL
Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
[TBL] [Abstract][Full Text] [Related]
35. Murine Bone Marrow-Derived Dendritic Cells Transduced by Light-Helper-Dependent Herpes Simplex Virus-1 Amplicon Vector Acquire a Mature Dendritic Cell Phenotype.
Oz-Arslan D; Tsitoura E; Kazazi D; Kouvatsis V; Epstein AL; Mavromara P
Hum Gene Ther Methods; 2015 Jun; 26(3):93-102. PubMed ID: 26046494
[TBL] [Abstract][Full Text] [Related]
36. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
37. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
38. Analysis of two potential shuttle vectors containing herpes simplex virus defective DNA.
Bear SE; Colberg-Poley AM; Court DL; Carter BJ; Enquist LW
J Mol Appl Genet; 1984; 2(5):471-84. PubMed ID: 6090565
[TBL] [Abstract][Full Text] [Related]
39. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging.
Wu X; Leduc Y; Cynader M; Tufaro F
J Virol Methods; 1995 Mar; 52(1-2):219-29. PubMed ID: 7769035
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes.
Schmeisser F; Weir JP
BMC Biotechnol; 2007 May; 7():22. PubMed ID: 17501993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
